The Cost of Solving the Wrong Problem

It's planning season. Revenue came in below plan. Everyone agrees something needs to change. Now you have to decide where the next dollar goes.

The requests are already on the table. Sales wants two more AEs. Enablement wants a new training program. Marketing wants budget for new content and a demo refresh. Demand gen wants more pipeline spend. Product wants the roadmap item customers keep asking for.

Every request has a sponsor, a business case and a price tag. And every one of them is a bet on the same unanswered question: why are we losing revenue?

Companies rarely lack options. What they lack is evidence about which option will produce the greatest returns.

Different Problems Can Produce the Same Revenue Miss

When revenue comes in below plan, that's the symptom. The cause could be capacity. It could be sales skill. It could be weak positioning or collateral. It could be insufficient pipeline. It could be a product gap.

From the financial result alone, you can't tell. That's why five teams can look at the same revenue gap and each make a credible case for their own fix.

Every Fix Has a Price Tag

There are plenty of places to invest to hit your targets. The hard part is knowing which one addresses the problem actually costing you revenue.

• Capacity → hiring. "We don't have enough sellers." A single seller can run around $250K a year, before ramp time.
• Skills → training. "Our reps can't run discovery or handle objections." A serious enablement program can run up to $200K.
• Sales assets → marketing spend. "Buyers don't understand the value." New content, collateral, case studies and demo builds.
• Lead generation → demand spend. "We don't have enough pipeline." More paid media, events, SDR capacity and tools.
• Product → roadmap. "We're missing capabilities." Roadmap work can easily pass $1M in engineering time, plus whatever you didn't build instead.

Every option can be the right solution. But only if it addresses the right problem.

Get the Diagnosis Wrong, and You Pay 2x

When the diagnosis is wrong, 3 things happen.

1. The spend doesn't return. Two new AEs cost around $500K a year. If the real problem was positioning, you now have two more people losing deals the same way.
2. The metric doesn't move. Win rate stays flat. Pipeline grows, but conversion doesn't. CAC rises. The board asks why the investment didn't work.
3. The next guess gets funded. The team decides the first fix wasn't enough and moves to the next theory on the list. Another quarter. Another budget line.

The direct cost is the money spent on the wrong fix. The bigger cost is everything else: the right fix that didn't get funded, the quarters lost while the real problem kept costing deals, and the credibility spent defending an investment that didn't pay back.

The Most Expensive Fix Isn't Always the Right One

Some revenue problems do require expensive fixes. Sometimes you need more sellers. Sometimes the product really is missing a capability that decides deal after deal.

But when we do buyer interviews for clients, they surface problems that need neither. When our team reviewed 125 win-loss interviews we've run for our clients, five recurring categories showed up: unclear positioning, weak proof, a business case that didn't hold up internally, buyers who weren't ready to implement, and real product gaps.

Only one of those categories requires a product change. Those distinctions matter because the fix may live in a completely different budget.

You don't want to fund 6 months of engineering to solve what was actually a value proof problem. And you don't want to hire more sellers when the existing team keeps losing on the same positioning issue.

The question isn't which fix is cheapest. It's diagnosing which problem you actually have.

A Real Case: What the Right Diagnosis Is Worth

One of our clients is a heritage luxury menswear brand, nearly 100 years old.

2 years ago they saw churn increase by 10%. Leadership responded the way many growth teams would: modernize. New designs. Updated pricing. More innovation.

The new designs underperformed. Internally, teams disagreed about direction.

When we spoke to 20 of their customers, the picture became clear. They valued what the brand had always done well: quality, design flexibility and a classic, understated style competitors couldn't match. The modernization push had moved the brand away from the reasons people bought.

Customer: "Best price for its value as a high-quality, full-canvas garment."

The company scaled back the new designs, reinvested in its heritage line, refined pricing around value for quality, and cut overproduction and wasteful R&D.

The result: $4M in added ARR within six months, 98% retention (a company record), a 15% reduction in churn, and more than $2M saved in product development.

It isn't a SaaS company, but the pattern is the same. The investment was going to the wrong problem until customers explained the right one.

Before You Fund the Fix, Test the Diagnosis

Metric → competing theories → buyer evidence → diagnosis → fix.

Buyer evidence decides which bucket the problem belongs in before the budget does.

In planning, the fix comes with a price tag, so the evidence step matters most. Before you approve the next major investment, test it against what buyers actually said:

• Hiring? Ask lost buyers whether they felt underserved: slow responses, missed follow-ups, no one available. If not, capacity isn't the problem.
• Training? Ask whether discovery understood their problem and whether their concerns were handled. If buyers describe strong conversations, skills aren't the gap.
• Content and assets? Ask what they needed to see to feel confident, and whether they could explain the value internally.
• Demand spend? Ask whether the right buyers are entering the pipeline at all. If good-fit buyers are losing, more of them won't fix it.
• Roadmap? Ask whether the missing capability decided the deal, or was one objection among several.

Buyer interviews don't replace financial or pipeline data. They add context around what's missing before a major investment gets approved: why buyers decided the way they did.

Don't make a $500K decision on data that shows the symptom but can't diagnose the cause.

Frequently Asked Questions

How should we decide where to invest to improve win rate?

Start with why deals are lost, from the buyers who made the decision. Then fund the fix that matches the cause. Hiring, training, content, demand and roadmap each solve a different problem.

Isn't pipeline and CRM data enough to guide budget decisions?

It shows where revenue is being lost. It doesn't show why. Two teams can read the same pipeline report and justify opposite investments.

When is hiring or product investment the right call?

When buyers point to it. If they describe slow responses and coverage gaps, capacity is real. If the same missing capability decides deal after deal, the roadmap is the right place for the money.